sk&f 81297 and 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol

sk&f 81297 has been researched along with 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichimaru, Y; Mori, T; Murase, K; Tanaka, J1
Liang, SL; Pan, JT1
Floresco, SB; St Onge, JR1

Other Studies

3 other study(ies) available for sk&f 81297 and 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol

ArticleYear
Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice.
    Japanese journal of pharmacology, 1997, Volume: 73, Issue:3

    Topics: Analysis of Variance; Animals; Benzazepines; Benzopyrans; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Motor Activity; Oxazines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, kappa; Tetrahydronaphthalenes

1997
Potent inhibitory effect of selective D2 and D3 agonists on dopamine-responsive dorsomedial arcuate neurons in brain slices of estrogen-primed rats.
    Life sciences, 2001, Oct-19, Volume: 69, Issue:22

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Benzazepines; Benzopyrans; Brain; Dopamine; Dopamine Agonists; Drug Interactions; Estrogens; Female; In Vitro Techniques; Mediodorsal Thalamic Nucleus; Neurons; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3

2001
Dopaminergic modulation of risk-based decision making.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3

    Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Benzopyrans; Bromocriptine; Conditioning, Operant; Decision Making; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Naphthalenes; Oxazines; Piperazines; Pyridines; Pyrroles; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reinforcement Schedule; Risk; Salicylamides

2009